Literature DB >> 20601255

Esophageal cancer: an update.

C M Shahbaz Sarwar1, James D Luketich, Rodney J Landreneau, Ghulam Abbas.   

Abstract

Esophageal cancer continues to be a lethal disease with the majority of patients presenting at an advanced stage. The incidence of adenocarcinoma is rising. Although Barrett's esophagus has been well characterized, specific pathways to the development of adenocarcinoma remain undefined. Current treatments for locoregional esophageal cancer include surgery, chemotherapy, radiation therapy, or a combination of these modalities. Optimal surgical treatment strategies include appropriate patient selection, accurate staging and risk assessment, selection of an appropriate surgical approach, and the use of multimodality treatment. This article provides an update on the myriad of options for managing esophageal cancer and outlines the surgical technique for minimally invasive esophagectomy used at our center.
Copyright © 2010 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20601255     DOI: 10.1016/j.ijsu.2010.06.011

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  33 in total

1.  Transplantation of tissue-engineered cell sheets for stricture prevention after endoscopic submucosal dissection of the oesophagus.

Authors:  Eduard Jonas; Sebastian Sjöqvist; Peter Elbe; Nobuo Kanai; Jenny Enger; Stephan L Haas; Ammar Mohkles-Barakat; Teruo Okano; Ryo Takagi; Takeshi Ohki; Masakazu Yamamoto; Makoto Kondo; Katrin Markland; Mei Ling Lim; Masayuki Yamato; Magnus Nilsson; Johan Permert; Pontus Blomberg; J-Matthias Löhr
Journal:  United European Gastroenterol J       Date:  2016-02-19       Impact factor: 4.623

2.  Expression patterns of three regulation enzymes in glycolysis in esophageal squamous cell carcinoma: association with survival.

Authors:  Wenfeng Li; Zhengyang Xu; Junfeng Hong; Yunsheng Xu
Journal:  Med Oncol       Date:  2014-07-27       Impact factor: 3.064

3.  Decreased expression of RASSF1A and up-regulation of RASSF1C is associated with esophageal squamous cell carcinoma.

Authors:  Wei Guo; Lei Cui; Cong Wang; Yanli Guo; Supeng Shen; Gang Kuang; Zhiming Dong
Journal:  Clin Exp Metastasis       Date:  2014-04-23       Impact factor: 5.150

4.  RASSF5A, a candidate tumor suppressor, is epigenetically inactivated in esophageal squamous cell carcinoma.

Authors:  Wei Guo; Cong Wang; Yanli Guo; Supeng Shen; Xin Guo; Gang Kuang; Zhiming Dong
Journal:  Clin Exp Metastasis       Date:  2015-01-13       Impact factor: 5.150

Review 5.  Minimally invasive staging of esophageal cancer.

Authors:  Kunal Mehta; Valentino Bianco; Omar Awais; James D Luketich; Arjun Pennathur
Journal:  Ann Cardiothorac Surg       Date:  2017-03

6.  Aberrant hypermethylation of RASSF2 in tumors and peripheral blood DNA as a biomarker for malignant progression and poor prognosis of esophageal squamous cell carcinoma.

Authors:  Wei Guo; Zhiming Dong; Jianli Cui; Yanli Guo; Supeng Shen; Xin Guo; Gang Kuang
Journal:  Clin Exp Metastasis       Date:  2016-01       Impact factor: 5.150

7.  Assessment of epidermal growth factor receptor mutation/copy number and K-ras mutation in esophageal cancer.

Authors:  Kang Guo; Wu-Ping Wang; Tao Jiang; Ju-Zheng Wang; Zhao Chen; Yong Li; Yong-An Zhou; Xiao-Fei Li; Qiang Lu; Lan-Jun Zhang
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

8.  Aberrant methylation-mediated silencing of lncRNA CTC-276P9.1 is associated with malignant progression of esophageal squamous cell carcinoma.

Authors:  Wei Guo; Shengnan Liu; Zhiming Dong; Yanli Guo; Chunyan Ding; Supeng Shen; Jia Liang; Baoen Shan
Journal:  Clin Exp Metastasis       Date:  2018-03-10       Impact factor: 5.150

9.  Meta-Analysis for the Therapeutic Effect of Neoadjuvant Therapy in Resectable Esophageal Cancer.

Authors:  Yusen Zhu; Min Liu; Xiaojing Yun; Dongmei Wang; Yuhuan Bai; Guizhi Zhang; Bei Ji; Changchun Jing
Journal:  Pathol Oncol Res       Date:  2016-12-24       Impact factor: 3.201

10.  Decreased expression and aberrant methylation of Gadd45G is associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma.

Authors:  Wei Guo; Tienian Zhu; Zhiming Dong; Lei Cui; Minghui Zhang; Gang Kuang
Journal:  Clin Exp Metastasis       Date:  2013-06-21       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.